BioMerieux (XPAR:BIM) Total Stockholders Equity : €3,868 Mil (As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is BioMerieux Total Stockholders Equity?

BioMerieux's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €3,868 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioMerieux's Book Value per Share for the quarter that ended in Jun. 2024 was €32.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioMerieux's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.14.

BioMerieux Total Stockholders Equity Historical Data

The historical data trend for BioMerieux's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Total Stockholders Equity Chart

BioMerieux Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,203.90

2,431.10

3,112.20

3,604.20

3,752.20

BioMerieux Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															3,469.00	3,604.20	3,627.30	3,752.20	3,867.80

BioMerieux (XPAR:BIM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioMerieux's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3867.8	-	0)	/	117.929
	=	32.80

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioMerieux's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(185.1	+	373.4)	/	3867.8
	=	0.14

BioMerieux Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioMerieux's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (XPAR:BIM) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BMXMF:USA BIMp:UK 0RUG:UK EYWN:Germany

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines